Figure 6.
Significance of tRF3-Ile AAT-1 and tiRNA5-Lys-CTT-1 in clinical practice. (A, B) Diagnostic value of tRF3-Ile AAT-1 in LNs with proteinuria (2+)/ (1+) and SLE without LN patients. (D, E) Diagnostic value of tiRNA5-Lys-CTT-1 in LNs with proteinuria (2+)/ (1+) and SLE without LN patients. (C, F) Correlation between tRF3-Ile AAT-1, tiRNA5-Lys-CTT-1 and the activity of SLE measured by SLE-DAI 2000 (0-4, no activity; 5-9, mild activity; ≥10, moderate to severe activity).